Back

Plasma natriuretic peptide level is an independent determinant of major clinical outcomes in atrial fibrillation patients without heart failure: The Fushimi AF Registry

( - )
Organised by:
Congress Presentation Part of: Abstract Programme Clinical ESC Premium Access ESC Asia with APSC & AFC 2020

About the speaker

Photo
Doctor Yasuhiro Hamatani

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

238 More presentations in this session

Presentation thumbnail
2-year real-world outcomes of prasugrel, ticagrelor or clopidogrel therapy following percutaneous coronary intervention from a large multi-centre Australian registry.
Doctor D. Pol (Melbourne, AU)
Abstract
Presentation thumbnail
3D right ventricular ejection fraction and longitudinal strain are independent predictors of major adverse cardiovascular events in patients with rrhythmogenic right ventricular cardiomyopathy
Assistant Professor L. Hosseini (Bojnurd, IR)
Abstract
Presentation thumbnail
A novel pressure-regulated deployment strategy for improving the safety and efficacy of balloon-expandable transcatheter aortic valves
Doctor A. Snir (Oxford, GB)
Abstract Video
Presentation thumbnail
A novel therapeutic approach for coronary inflammation and lymphatic vessels using non-invasive low-intensity pulsed ultrasound in a porcine model with DES-induced coronary hyperconstricting responses
Doctor T. Watanabe (Sendai, JP)
Abstract Video
Presentation thumbnail
A real-world comparison of outcomes between fractional flow reserve-guided versus angiography-guided percutaneous coronary intervention
Doctor C. Wong (Sydney, AU)
Abstract

Access the full session

Session thumbnail
Abstract Programme

The Event

Event poster

ESC Asia with APSC & AFC 2020

You may be interested in
thumbnail
Congress Presentation
Evaluation of the diagnostic significance of various types of natriuretic peptides in patients with heart failure on the background of atrial fibrillation and chronic obstructive pulmonary disease
29 June 2021
thumbnail
Congress Presentation
Impact of body mass index on outcomes in european patients with atrial fibrillation: the ESC EHRA EORP Atrial Fibrillation General Long-Term Registry (AFGen LT)
30 August 2020
thumbnail
Congress Presentation
Prognostic markers of atrial fibrillation after stemi
2 March 2019
thumbnail
Congress Presentation
Is atrial fibrillation an independent predictor of mortality in patients with heart failure and a reduced left ventricular ejection fraction?
1 July 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources